Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 Biomarker disease BEFREE Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis. 29276215 2018
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 Biomarker disease BEFREE To investigate the effect of total flavone of haw leaves (TFHL) on the expression of nuclear factor erythroid-2 related factor (Nrf2) and other related factors in nonalcoholic steatohepatitis (NASH) rats induced by high-fat diet and then to further discuss the mechanism of TFHL's prevention against NASH. 26919834 2018
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 Biomarker disease BEFREE Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet. 26679056 2016
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 Biomarker disease BEFREE Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. 27634173 2016
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 AlteredExpression disease BEFREE p62/SQSTM1 is a multifunctional signaling hub and autophagy adaptor with many binding partners, which allow it to activate mTORC1-dependent nutrient sensing, NF-κB-mediated inflammatory responses, and the NRF2-activated antioxidant defense. p62 recognizes polyubiquitin chains via its C-terminal domain and binds to LC3 via its LIR motif, thereby promoting the autophagic degradation of ubiquitinated cargos. p62 accumulates in many human liver diseases, including nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), where it is a component of Mallory-Denk bodies and intracellular hyaline bodies. 27404485 2016
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 Biomarker disease CTD_human Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice. 25294219 2014
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 Biomarker disease BEFREE Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model. 23592516 2013
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.400 Biomarker disease BEFREE Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways. 22364184 2012
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 AlteredExpression disease BEFREE Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα. 30975991 2019
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 Biomarker disease BEFREE Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan. 30850637 2019
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 AlteredExpression disease BEFREE Osthole, a coumarin derivative, can increase hepatic peroxisome proliferator-activated receptor α (PPARα) expression and reduce hepatic steatosis and inflammatory response in rats with non-alcoholic steatohepatitis (NASH). 30659956 2019
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 Biomarker disease BEFREE Finally, PPAR-α/δ dual agonist induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. 28098353 2018
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 Biomarker disease BEFREE We established a mouse model of developmental nonalcoholic steatohepatitis (NASH) by feeding a high polyunsaturated fat liquid diet to female glutathione-S-transferase 4-4 (Gsta4<sup>-/-</sup>)/peroxisome proliferator activated receptor α (Ppara<sup>-/-</sup>) double knockout 129/SvJ mice for 12 weeks from weaning. 27998724 2017
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 Biomarker disease BEFREE Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. 28195199 2017
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 AlteredExpression disease BEFREE PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. 25703085 2015
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 Biomarker disease CTD_human Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. 23603006 2013
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 Biomarker disease BEFREE Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. 23603006 2013
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.390 GeneticVariation disease BEFREE Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis. 16297361 2005
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.380 Biomarker disease BEFREE Angiotensin-(1-7) improves non-alcoholic steatohepatitis through an adiponectin-independent mechanism. 26992300 2017
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.380 GeneticVariation disease BEFREE The people who carried the adiponectin gene promoter -11377C/G (GG)/GPx-1 gene C594T (TT) had a high risk of NAFLD (ORNAFL = 7.2800; ORNASH = 41.2941; ORNAFHC = 363.9724), and statistical analysis suggested a positive association between -11377C/G (GG) and C594T (TT) in increasing the risk of NAFLD (γ2NAFL = 2.2071, γ4 NAFL = 2.0773; γ2 NASH = 2.1084; γ4NASH = 2.0543; γ2 NAFHC = 2.1387; γ4NAFHC = 2.0004). 26897098 2016
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.380 Biomarker disease BEFREE MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis. 21791204 2011
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.380 Biomarker disease CTD_human The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. 20415685 2010
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.380 AlteredExpression disease BEFREE Variations in adiponectin levels could be an indicator of disease progression since inflammatory infiltrates are commonly associated with nonalcoholic steatohepatitis (NASH) in morbidly obese patients. 20041267 2010
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.380 Biomarker disease BEFREE Nitrotyrosine and adiponectin concentrations and vitamin A intakes independently predicted alanine aminotransferase concentrations in NAFLD patients and liver histology in a subgroup of 29 subjects with biopsy-proven nonalcoholic steatohepatitis. 17823431 2007
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.380 AlteredExpression disease BEFREE Serum adiponectin level was the only predictor of nonalcoholic steatohepatitis (NASH) in this study (P=0.024). 16989692 2006